OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-12-31-accounts

Charity Commisslon Reglstratlon No. 286363 THE BRITISH MEUROPATHOLOGICAL SOCIETY FINANCL4L STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2023

THE BRITISH NEUROPATHOLOGICAL SOCI LEGAL AND ADMISTRATIVE INFORMATION Trustees Stephen Wharton (Presrdentl T8mmaryn Lashley ￿le6 President DanEI thj Ple5sis (Treasurer) Accountants Orcom Ciw318 Limffted Chart8red Accountants 50 Seymwr Street London W1H 7JG ank Bank of Sc¥)tl3nd 174 8yr8s Road Gjasww G12 8SW COIF Charty Funds CCLA Investment Management Ltd Sl Alpha9e House 2 Fore Street London EC2Y S4Q Prlncl l Add 50 Seymour Street London W1H 7JG Chari Cornmlsslon Re Istratlon Number 286363

THE 8Rm8H NEURQPATHOLOGICALSOCIETY TRUSTEES REPORT Thg Trustees present th8ir 8nnu81 reput on the affairs of the Socw tog8th8r the fingnd81 stalemgnts 80d S￿epenthnt examhers repts￿ for y8ar ended 31sl Decefftber 2023.The fmancial ststements have b2en prepared in accordarKe vAth the arxountsry pollcies sol out in note 1 lo the accounts and CO￿pty ￿1th the chariws lrnst de&J, the Chadll88 Act 2011 and A(￿￿tIng Reportiw by. Charities.. Stalernent of RBcLYnm•nded PraGtir8 appllcablo ) tharitEs preparfng tsir aco)unts in rdar¢Milh th8 Fina￿•&1 ReporbTrJ Standd applicab￿ In tha UK aThl RowNic of Ir818nd pU￿1Shed On 16 July 2014. mlnlstr The &)c4ety is re￿¥[ered 85 a ehaiity ITh the Unltod Kw(S)m, nurt¢r 286363, rfs operations are subject to tha Chgrthe8 196Qts2011. Th8 obina of Ihe is to fvrtherth8 SttJ(ty of nwjvopathobuy. to prDrnr4e the excthan￿ of sdon1￿C IrrfomwivJn by rne8￿ regU￿r and d&nonstrations, and bj kYovldE the OpF￿nun1ty for dW58knn$ bèll￿en Muropthbai8ts in 8rftaln and 01herC4￿ntneS. Iw5te88 cvn5klerthat by meeting these obpctlves ufill a150 meetthe Pu￿￿ Ben8fj1 tèst applk8bl& It) 511 Choribe%. The lknanaal statements ofthe s￿￿ty pro¥kl& dotBtL8 of mr ¥tivIt￿5 ￿￿dOn 8nd htrwlhe actNits86 have bpgn flnar￿a￿. The &)dety hes threa rpthc￿1 htnd$ fv obits ofthlch are... Doroty Fkn$5ell and A￿e￿ Mey6r Memorial Fury￿8 To provide 8G4enlifiG S￿￿PoSI￿M arKI thr8s h) 8tternate yas NEQAS Fund To pro￿d8 qu81ty 858urarK In re￿I￿)n to re￿0pa￿)￿9v. to bnpro¥8 Stsno4￿l5$ d￿￿$t neuropalho&)gy. The Trustees I￿ted on rAgg 1. Is•tlon The So¢loty reli88. 4nd to rety. on ts voljntary w>rk und8rtaken by th8 Iru8tees. member8 ol u)mmih•s and ttthervotyJnt8ers, Sotiety has no 0￿￿8Q9. The tru818t3 are eW8d by tho m8fflLr5 and, lo11￿￿ e￿tk)n, serve 8 fixod term at t￿ ènLI af which they may Sta￿ for feel8￿on if there are no oth8r tArKlidates. Trustees und8rt8ke their M traninp to 8nsu they achleve ththrffidU￿ry du￿08. Thg Iruste8s metst atthe Sr￿&￿6 bwhBys rneetirws Mice & year at tkn8 str8teglG deri¥icfts ar6 tak8n. The trI￿lee and o)mmitt meling5 ar8 designed to prtsrnolfj Cer￿￿trate odU¢offiOn￿ aThJ Éden￿ velue of th8 Irustee8 have a poh"tytDiden m￿Senta￿￿ ofthp rnAmb8rs on Lwmlttees. Thts kn&ty18 affilatad to various Europ8an bodies nD formal responsi￿lItI￿g lo I￿8￿ Dru￿￿￿tIO1 a￿&1. are no relwt8d part￿5 or subsldiBries.

TrrE BRITISH NEVR0PAThOLOGIC￿ 80CETY TRUSTEes REPORT The buste85 are ￿rMItt￿ to m8 Bny ￿n￿lment that theyge8 ffl, bjt in VEW of Ih• current fin¢iql ￿m￿le r¥)nBider the b2Jt ar￿geMqnts ft)i swplusfurK18 are Sth ts chori1￿8 Invgsrm8nt F￿)d. The Trust08s regularly roV￿W thg &tivit￿$ and consid6r the OPP￿￿￿11$ •vailable to th8 charlty to £nab￿ k to m88t its obiecfve5 and the rtsks to il ￿ ewosed. As parl of pror￿& thè Iru8tsBS revl&w th8 risks wknich may face. tslabllsh sySterTrs procedure5 to mitigate th050 llsk5 idantified and imp￿m￿nI pr¢c•lurBs d88iwed to rThAmi5e any tew impxt cm the chartyshuuky anyof iho5e ii&k¥ mqteri&lise. The systems are thslgned &) provide r6asanable, but notab80￿, assurarts agai￿1 mthal mL5St818mentorlDS¥. ThBy In¢lud8 reguLw ¢onswJèrBkn fman¢io1 results. varianre frem b￿gets, of duri95 and the idonofication and matwoemhl of ii8ks. C4)mr￿tt&e are tohsdous that In rocent years Ihe Tr8e+ves of the Sodety have incr8atsed to è greater bvel than y￿uld bè requir&1 to malntain aclvitie5 evèn If fvnding frorn IhB journal were to reduce conSKJerably. It Ih6'Trustees Intenlbn th reslri¢l8d fvnds shouky be r&lutsd to approximatety £250,OQO over forthcoming years. This wll bÈ achk8v2d by an in(yeas6 number of re888rch orarrts vthere 5uliable preitscts 8r& proposed 8n(S IrKrea$￿ aC•Jem￿, Iralning and Èducthnal ath￿￿$. L8 a180 hoped to achbve d￿rIaliZatiOn and cO￿Puter￿a￿Dn -onl1r￿ for socw rne8tings EQA8, for trits a troinl programmè members has akWb8gun. Chliy requtro5 TI￿tea& to pr8pAre fmBnry81 stotem8nts lor èach fmanciBI year whlch gwe a true 8TrJ fair vknw ol Ihe slale of affelrs ol Charty and of th8 resuts of the Chailty for th8 pernd. together ￿7th tls as9eL% and lablNIEs at eThY of lh8 period arKI adequately distiwuksh any rnaleri818PqCi81 trusi or other re51rthi fund of Ihtr thty. In k¥•poring tt stst8manty th8 frustees are requlrad lo.. S8l&tsultablè aco)untw pok405 arhj Ihen appty them con6thnty, lake judgerr￿￿8 eslvnales that aro reasonabk 8ThJ yud8n state wh8ther poll￿ adopted are in acc(￿danCe Ihe approprK9t& SORP on A￿u￿lIng ty charl￿ 8rKI lh8 Affounting R8gulaliDn5 snd wllh appThC£b￿ sttouDtsrvJ 5taThJwds, to any rn81thal daparturas disclosl explwMd in lh9 fin8nc4al Bt8tsments." and Prepare the financ￿1 statemèhts the Wng 0)nctrn basL4 unb88 it is Inapwopriate lo pr8$ume tsl Ihe Ch8rKy n wntlnu8 in buts￿8. Trustees are rgsponslbk for keeplng woper aco)unWr@ re￿r￿S wthich dlSGb88 ith reasonabk8 ac£uracy al 8Try lirnB lknandl p05nion of the Charity and to enable them to ensure that the flnancbl Statements r￿pIY vAth apPI￿ablY A¢¢x)untlng standards and Statemen& Df Reu)mmended PradK8 and Ihè wuLq1tD￿ marfB of the Chariti85 Act 1993. They are 480 responsible lor Safeguarding ihè assèts of the company and henc8 for taking re8$0nabb stèps lor Ihe preVent￿n 8Th1 d8tethn ¢ffraud Ond oth* irregularrb88. Profe5sorStephen Bwharton 6NS Presidert IOthoctober2024

BNS British Neuro atholo iral Socl Presldenys Re The 124 Annual Soclety Meeting was held on the 1-3 March 2023, with a return to an Sn-person meeting and a full 3-day programme aimed at covering both Scientific and clinical practbce elements of neuropathology. The meeting is therefore aimed broadly at both researchers and dlagnostic neuropathologist. The meeting remained popular with 159 attendees. The attendance fee was subsidi5ed for students, early career ￿SearCherS and trainees re8lStrants in order to promde educational opportunlty for those at an earty stage of their careers and to encourace an interest in nèuropathology. The meeting opened with the Symposium on Skeletol Muscle Disorder5, covering recent advances in pathology, genetics and therapy. The Alfred Meyer memorlal lecture was given by Prof Werner Stenzel, from Germany, on myositls. The meetlng provided 5 scientific sessions and 26 poster presentation5, a substantial Increase over last yearfs on-line meeting. Shorter"flash" presentstions were a new introduttion. designed to allow early Career researchers an opportunity to gain presentatlon experience. A further Snnovation was the introduction of a clinical update sesstsn. Aimed at diagnostic neuropathologists, two t￿kS were given by a leading expert, Prof Arie Perry, from the Unlversity of Callfornia. A discussion sesslon was held for the diagnostlc External Quality Assurance IEQAI scheme (see below). Sessions were also held for the Professlonal Affairs Committee, whlch examines matters relevant to cllnicèl practice in diagnostlc neuropathology, and for the general Buslness Meeting of the Society. Ort 2023 The Socievs aim of providlng continued further educatlon was addressed via the organtsation of educational everrts. The BNS sponsored a symposium at the Brit15h Neuroscience Assoclation conference in Brighton and this was organised by BNS members. The theme was 'lmmunotherapy in neurodegeneTrtTve disease5" and was very well attended. Planning was Jlso begun to restart the BNS residential summer school in 2024, which will be held at Cirencester with the theme of 'Yechnology advan￿MentS pushing the boundaries of neuropatholo8y dia8n05tic and research". The BNS made a contribution l£lOtKJl to the Royal College of Patholo815ts summer 5ch¢)ol. This is deslgned to encourage interest In pathological specialtles, and our contribution allows us to promote neuropathology to undergraduates. The Society continue5 to run its small research grant and bursary scheme5 to support early research activity and provSde pilot data for projects. with a value of up tts £5000, the BNS awarded 10 resèarch grants out of l- submitted, split between Spring and Autumn round5 (total value £50,000). These are administered by the Academic Chair Jnd supported by review from the academic subcommittee. There were 7 application5 for travel bursaries, all funded, and 8 applications from Junior staff to attend the 8N5. The BNS scheme to fund electThie5 for medical students was open again this year but none of the 3 applications were related to neuropathology and 50 were out of scope for the award. A declsion was taken to increase the value of travel bursarles from £5￿ to £750 to reflect tncrèasing costs of attending meetings. The society further.supports the International Soclety of Neuropathology IISNI and the European Neuropathology Soclety IEuroCNSI

vla payment of yearly per capita member 5ubxription fees. which allows BNS members to engage with these bodles and their activitles/publication5, Including access to the EuroCNS loumal, Clinical Neuropathology. The BNS funded 3 places for diagnostic neuropathol(￿ tralnees to attend diagn05tic tralning courses in Europe, organlsed by EuroCNS. The society is also affiliated to the Jolnt Neurosciencès Counsel of the United Kingdorn. The soclety's finances continue to benefit from royalties generated by its journal, Netsmpathohgy ondAppliedNeurobiology. The journal is published on behalf of the Society by Wiley. Royalties recelved constitute the bulk of the societvs annual income as in the past. The society subsidises members, subscription to NAN Iboth the onllne and paper coples of the journal). though the higher membership fee. which ha5 now been implemented will decrease the subsldy. No fundraising actl¥ities are undertaken by the soaety. The Society contlnues to provlde substantial support to maintaining diagrK)stic neuropathology as Gmc-recognised irbdependent medical special￿¥ with conslderable engagement in the recruitment, curriculum setting and assessment activities relevant to the speciality. This includes the development of standards documents by the professional affairs Committee. The Society bankrolls a model External Quallty Assurance IEQAI Scheme, whlth is fulty digitlsed. Hlgh level participation and continuous review of the scheme ensures continued public Confiden￿ in the national neuropathology service. The 8NS also maintains a website Iwv*w.bns.or .uk l ès a portal to inform members of thè 5ocietVs activitles and award schemes. WÈ contlnue to update this and a project to upload archival documents from British Neuropathology has been carried out. Pn>fessor Stephen B Wharton 8NS President 2022-204

THE BRITISH NEUROPATHOLOGICAL SOCIETY INDEPENDENT EXAMINERS REPORT TO THE TRUSTEES I report on tho accounts of the Tru81 lor the y8ar ended 31 Dècember 2023, whi¢h are 9el out on p￿e5 6 to 9. Respectlve r•sponslbllltles 01trust￿ and •xamlnor Th8 ch8rTrty's Iru8té8$ are rnsponBible lor the preparation of the acwunts. The th8ritys trustees ¢onslder thal an audit Is not required for this year under s8ction 144121 of Ihe Charities Act 2011 (the Act) and that an ndependenl 8xamination is rded. examine lh8 accA)unts under S￿tIon 145 of the Aet: to folbw the proceduTes18id down In the General dlreclions giv8n by thg Charity Commi$8loner und8r se¢don 14515llbl of the Act,. and lo stat& whefvr parU¢ular matters have v)me to my attention. Basls of Indepfrndent •xamlngfB' report examinauon was caftied out in &cordanc¢ wlth the General Directlons given by Ihe c1￿￿ty Cornmi&sion8rs. An examination includes a review ol thg accounting records kept by the charity and comparrson of the accounts prgsent8d with thos& recoril3. It also includes o)nsideration Df any unusual items or discfosures In the a(xounts. and the seeklng ol explanations frorn you as trustees conceming any such rnatters. Tha procedures undertaken do not pro￿d& all th8 evid8nc8 th81 would be required In an audit and, o)nsequ8nUy, I do not express 8n audit opinion ¢)n the ¥A8w given by the accounts. Indep•nd•nt examlners. $tatennt In ojnnoction with my examination. no matter has come lo my att&nllon'. whSc* give8 me rea80nable cause to ￿lIeVe that, In any rnatertal respert Ihe rBqulrements'. to keep accountlng rec(xds In accordance vAth $130 of Ihe Actr, and to weparn 8ccotsnts whlch accord with the accounting records and to wmply with thè accounting uirem6nts of the Act have Thjt been met; or lo which, In opinion. attenlton should be drawn in onler to en8bl• a proper und8rstsTrJing of the acuJuntS to bo reached. M Gibbons FCA Orcom Clvvals Llmited Chartared Accountants 50 S8ynh)ur Sl London W1H7JG 10 October 2024

ThE aRmsH NEUROPATHOLOGICAL SOCIErY srATEMENT OF FINANCIAL ACTMTIES FOR THE YEAR ENDED 31ST DECEM ER 2023 NC END Total Total Fun Incomln SubscrIp￿n5 Surplus from Joum Interest r8¢&vable 29.390 146.595 15,083 191.068 450 29,840 9,970 146,595 146,475 17,380 193,815 2.297 2,747 143,672 Dlr4¢t eh Tllabh•x blishing Costs Cost of meolngs Event8 Grnrsts & spon50wship Subscriplitins EQA costs ￿dI￿re. 8.882 66,969 8.882 66,969 8.753 3,670 19,404 71,940 16,183 790 120.740 58.083 6.137 58.083 6,137 140,071 rt•x ndltur¢: Comrnittee 8xpèn88S Webslte deslgn Adminislr4tiv8 ¢05ts Bank Charges Ath)untsttry 140,071 4,305 4.005 114 3.210 11.694 4.305 4,005 114 3,270 11,694 4.612 2,820 7.606 TOTAL EXPENDilliRE 151.785 151.Te5 128,34fj NEf INCOME FOR ThE YEAR 39,303 2,747 41050 28.110 Fund trolances Lyoughtforward 605,377 49,156 654.533 626,434 FUND 8ALANCES CARRIED FORWARD £644,680 £51,903 £696,583 £654.534

HE BRITISH NEUR PATHOL GICAL SOCIETY LANCE HEET AS AT STDE 2023 Note CURRENT ASSETS Cash deposits 702,463 702,463 671,3 671,350 ss: URREfrif LIABIUTIES Creditors 10,816 14ET CURRENT ASSETS 696.583 654,534 Total nti illtle Represented by.. Unrestricted F nd8 Ggneral Purpose Funds 644,680 605,378 R￿tricted Fund* Dtsrothy Russell MerrKJrial Fund Ajfrgd M&y¢r Memc¥ial Fund NEQAS Fund 4,818 46,444 641 4.582 44.383 191 51.903 69fj,58 49.156 654. Approved by the Trustees and signed on thglr behail on 10th October 2024 D DuPle Treas

THE BRMSH NEUROPATHOLOGICAL SOCI NOTES TO THE ACCOUNTS. FOR THE YEAR ENDED 31ST DECEMBER 2023 1. AccouTrifiNG POUCIES lal These Accounts refi0Ct all lunds hejd by the charity. whlch are govemed by the Bye Laws, adopted on 14th July 1977 as amended on 11th January 1991 and 3rd hrfarch 2021. The funds heky arg utilised in accordance with th6 trusts uthr which Trustee6 are empower•d in tho Bye Laws. (bl The financial stslem8nts have been prepared in ac￿rdanCe thg accounllng policie8 Bet wt in note I to tho accounts and ccffiply wth thg charity's trust deed. the Chwit(es Act 2011 and Accounting and Reportin9 by Charitias.. Statement of Recommendèd Practico applicable to charit18s pr8p8riro their acwunts in accordance Mth the Finanoal Rewrting Standard applirAb18 in th8 UK and Republic of Ireland publlshed en 16 Juty 2014. There has been ￿ change to the accounting polleJe8 (valuation rules and mothods ol a¢¢ounbngl since last year. {cl The 8CC4)unts have be6n prep8red under the historical co81 convention on an accruals basis and includ8 income and expenditvr8 as they are eamed or Incurred ratherthan as cash is réceiv￿ Or paid, except in the case of the sU￿lUS from lournal. which 15 aco)unted for wtpn re¢8lv&J from the publisher. ANALYSLS OF RESTRICTED FUPIDS Dorothy Alfred Russell eyer M8morfal Memorial FuTrJ Fund EQA Fund TOTAL eom• Sub$criptk)ns rec¢fvable Inte￿st rec•ive(I 450 450 2,297 2,747 236 236 2,IA1 2,061 450 Lecture costs Lalx)ratory costs Onllne subscriplion Net Inrxjme For Y8ar 236 2,061 450 2,747 Fund Balance Brought Forward 4,562 44,383 191 49,156 FUND BALANCE CARRIED FORWARD 4.818 46044 51,9Q3

THE BRITISH NEUROPATHOLOGICAL SOCIETY NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31ST DECEMBER 2023 23 202 . MEETINGS Megbrg wsls 66,969 66.969 3,670 3,670 4 GRANTS & SPONSOR HIP Research grants & burs8￿$ Swsorship 58,083 71,940 58.083 71,940 5 SUBSCRIPTIONS Euro CNS Intemalional Soclety of Neuropatholo 9,2 6,933 16,1B3 6,137 6.137 6. TRUSTEE EXPENSES Committee r<)om hire 144 144 Th8 trustees r8celv*J no ￿mu￿rat￿)n durfng the y&ar12022.' nlll H DEPOSITS Unrestrlcted general funds Unrestricl&Y joumal fund Oorolhy Russ811 Memorfal Lecture NEQAS Re8tn'cted lund Jfred ￿Ye1 MenK)rial Lecture 550,834 105,524 4,$94 1,282 40,229 702.463 527,869 100,117 4,364 832 38,168 671,350 CrBdito 5,880 5.880 16,816 16,816